These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 26105497)

  • 1. PP176. SFLT-1: A possibility of precocious diagnosis of preeclampsia.
    Olmos CS; Macedo MA; Pereira RM; Augusto V; Garcia JM; Panico VJ; Souza EV; Sato JL; Saito M; Sousa FL; Sass N
    Pregnancy Hypertens; 2012 Jul; 2(3):335-6. PubMed ID: 26105497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PP059. Angiogenic factors and risk of preeclampsia related adverse outcomes in twin pregnancies.
    Rana S; Hacker M; Merport A; Salahuddin S; Verlohren S; Perschel F; Karumanchi SA
    Pregnancy Hypertens; 2012 Jul; 2(3):273-4. PubMed ID: 26105382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [PlGF and sFlt-1--diagnostic significance in preeclampsia prediction in pregnant women with gestational and chronic hypertension].
    Manolov V; Marinov B; Vasilev V
    Akush Ginekol (Sofiia); 2013; 52 Suppl 1():61-9. PubMed ID: 24294749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Predictive value of the sFlt1/PlGF ratio for the diagnosis of preeclampsia in high-risk patients].
    Husse S; Gottschlich A; Schrey S; Stepan H; Hoffmann J
    Z Geburtshilfe Neonatol; 2014 Feb; 218(1):34-41. PubMed ID: 24595913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An automated method for the determination of the sFlt-1/PIGF ratio in the assessment of preeclampsia.
    Verlohren S; Galindo A; Schlembach D; Zeisler H; Herraiz I; Moertl MG; Pape J; Dudenhausen JW; Denk B; Stepan H
    Am J Obstet Gynecol; 2010 Feb; 202(2):161.e1-161.e11. PubMed ID: 19850276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary angiogenic factors cluster hypertensive disorders and identify women with severe preeclampsia.
    Buhimschi CS; Norwitz ER; Funai E; Richman S; Guller S; Lockwood CJ; Buhimschi IA
    Am J Obstet Gynecol; 2005 Mar; 192(3):734-41. PubMed ID: 15746665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. sFlt-1/PlGF ratio as a prognostic marker of adverse outcomes in women with early-onset preeclampsia.
    De Oliveira L; Peraçoli JC; Peraçoli MT; Korkes H; Zampieri G; Moron AF; Sass N
    Pregnancy Hypertens; 2013 Jul; 3(3):191-5. PubMed ID: 26106033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [THE ROLE OF ANGIOGENIC FACTORS IN THE DIAGNOSTICS OF PREGNANCY COMPLICATED WITH PREECLAMPSIA].
    Tagiyeva I; Aliyeva S; Bagirova S; Shamsadinskaya N; Agaeva K
    Georgian Med News; 2017; (268-269):35-38. PubMed ID: 28820409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maternal serum placental growth factor and soluble fms-like tyrosine kinase 1 as early predictors of preeclampsia.
    Shokry M; Bedaiwy MA; Fathalla MM; Alsemary A; Elwakil S; Murphy A
    Acta Obstet Gynecol Scand; 2010; 89(1):143-6. PubMed ID: 20021269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PP051. Prediction of preeclampsia with the sFlt-1/PLGF ratio: impact of the slope of repeated measurements.
    Schoofs K; Engels T; Pape J; Henrich W; Stepan H; Verlohren S
    Pregnancy Hypertens; 2012 Jul; 2(3):269. PubMed ID: 26105374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PP178. Antenatal sFlt1 and PlGF levels at 20-28weeks of gestation for prediction of the occurrence of preeclampsia: A preliminary report.
    Jantarasaengaram S; Tansatit T; Samkhoompim N
    Pregnancy Hypertens; 2012 Jul; 2(3):337. PubMed ID: 26105499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PP023. Soluble Fms-like tyrosine kinase-1 and placental growth factor expression in a rat model of pre-eclampsia.
    Liu L; Liu H; Brennecke S; Huang Q; Hu B
    Pregnancy Hypertens; 2013 Apr; 3(2):75-6. PubMed ID: 26105880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The ratio of soluble fms-like tyrosine kinase 1 to placental growth factor predicts time to delivery and mode of birth in patients with suspected preeclampsia- a secondary analysis of the INSPIRE trial.
    Palma Dos Reis CR; O'Sullivan J; Ohuma EO; James T; Papageorghiou AT; Vatish M; Cerdeira AS
    Am J Obstet Gynecol; 2024 Jun; ():. PubMed ID: 38897339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble vascular endothelial growth factor receptor-1 (sFLT-1) mediates downregulation of FLT-1 and prevents activated neutrophils from women with preeclampsia from additional migration by VEGF.
    Krysiak O; Bretschneider A; Zhong E; Webb J; Hopp H; Verlohren S; Fuhr N; Lanowska M; Nonnenmacher A; Vetter R; Jankowski J; Paul M; Schönfelder G
    Circ Res; 2005 Dec; 97(12):1253-61. PubMed ID: 16269656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Automated measurement of sFlt1, PlGF and sFlt1/PlGF ratio in differential diagnosis of hypertensive pregnancy disorders.
    Engels T; Pape J; Schoofs K; Henrich W; Verlohren S
    Hypertens Pregnancy; 2013 Nov; 32(4):459-73. PubMed ID: 23957293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum heat shock protein 70 levels in relation to circulating cytokines, chemokines, adhesion molecules and angiogenic factors in women with preeclampsia.
    Molvarec A; Szarka A; Walentin S; Beko G; Karádi I; Prohászka Z; Rigó J
    Clin Chim Acta; 2011 Oct; 412(21-22):1957-62. PubMed ID: 21756887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Performance of sFlt-1/PIGF Ratio for the Prediction of Perinatal Outcome in Obese Pre-Eclamptic Women.
    Karge A; Desing L; Haller B; Ortiz JU; Lobmaier SM; Kuschel B; Graupner O
    J Clin Med; 2022 May; 11(11):. PubMed ID: 35683415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PP058. The additive effect of plasma levels of sFlt-1/PLGF ratio following the risk classification using both blood pressure levels and uterine artery blood flow impedance in the second trimester on the later occurrence of preeclampsia.
    Ohkuchi A; Hirashima C; Takahashi K; Matsubara S; Suzuki M
    Pregnancy Hypertens; 2012 Jul; 2(3):273. PubMed ID: 26105381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PP054. Predicting preeclampsia at late mid-term pregnancy before occurrence of clinical symptoms: Clinical utility of biomarkers and clinical parameters in a low-risk population.
    Forest JC; Massé J; Bujold E; Lafond J; Charland M; Rousseau F; Giguère Y
    Pregnancy Hypertens; 2012 Jul; 2(3):271. PubMed ID: 26105377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. sFlt1/PlGF among patients with suspected preeclampsia when considering hypertensive status.
    Patel E; Suresh S; Mueller A; Bisson C; Zhu K; Verlohren S; Dadelszen PV; Magee L; Rana S
    AJOG Glob Rep; 2024 Aug; 4(3):100359. PubMed ID: 39005612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.